These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8765705)

  • 41. Alfacalcidol and calcitriol in the prevention of bone loss after organ transplantation.
    Sambrook P
    Calcif Tissue Int; 1999 Oct; 65(4):341-3. PubMed ID: 10485989
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Osteoporosis after renal transplantation.
    Trabulus S; Apaydin S; Altiparmak MR; Seyahi N; Sariyar M; Serdengeçti K; Erek E
    Nefrologia; 2003; 23 Suppl 2():127-30. PubMed ID: 12778869
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Update on gingival overgrowth by cyclosporine A in renal transplants.
    Ciavarella D; Guiglia R; Campisi G; Di Cosola M; Di Liberto C; Sabatucci A; Escudero N; Bascones A; Lo Muzio L
    Med Oral Patol Oral Cir Bucal; 2007 Jan; 12(1):E19-25. PubMed ID: 17195822
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effect of immunosuppression-induced hypogonadism on bone metabolism after heart transplantation].
    Stief J; Sohn HY; Alt A; Uberfuhr P; Theisen K; Stempfle HU
    Dtsch Med Wochenschr; 2004 Jul; 129(31-32):1674-8. PubMed ID: 15273918
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Degree of corticosteroid treatment within the first 2 months of renal transplantation has a strong influence on the incidence of osteonecrosis of the femoral head.
    Shibatani M; Fujioka M; Arai Y; Takahashi K; Ueshima K; Okamoto M; Yoshimura N; Hirota Y; Fukushima W; Kubo T
    Acta Orthop; 2008 Oct; 79(5):631-6. PubMed ID: 18839369
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Posttransplant diabetes. Metabolic consequences of posttransplant immunosuppressive treatment].
    Christiansen E
    Ugeskr Laeger; 2007 Jun; 169(24):2309-11. PubMed ID: 17594845
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of immunosuppressive therapy on hypertension.
    MacDonald AS
    Transplantation; 2000 Dec; 70(11 Suppl):SS70-6. PubMed ID: 11152235
    [No Abstract]   [Full Text] [Related]  

  • 48. Organ transplantation and glucocorticoid-induced osteoporosis.
    Giannini S; Nobile M; Sartori L
    Front Horm Res; 2002; 30():94-106. PubMed ID: 11892274
    [No Abstract]   [Full Text] [Related]  

  • 49. Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease.
    Bjøro K; Brandsaeter B; Wiencke K; Bjøro T; Godang K; Bollerslev J; Schrumpf E
    Scand J Gastroenterol; 2003 Mar; 38(3):320-7. PubMed ID: 12737449
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Secondary osteoporosis and glucocorticoid-induced osteoporosis].
    Orcel P; Krane SM
    Ann Med Interne (Paris); 2000 Oct; 151(6):497-503. PubMed ID: 11104930
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tumors after transplantation: are there associated factors?
    Jacobs U; Paar D; Buszello H; Klehr HU
    Transplant Proc; 1996 Dec; 28(6):3248. PubMed ID: 8962258
    [No Abstract]   [Full Text] [Related]  

  • 52. Nephrotoxicity associated with cyclosporine and FK506.
    Klintmalm GB; Gonwa TA
    Liver Transpl Surg; 1995 Sep; 1(5 Suppl 1):11-9. PubMed ID: 9346596
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Kidney transplantation in children].
    Wiesel M; Weber C; Mehls O; Pomer S; Möhring K; Staehler G
    Urologe A; 1994 Sep; 33(5):422-7. PubMed ID: 7974931
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diagnosis and management of osteoporosis in inflammatory bowel disease.
    Reinshagen M; Von Tirpitz C
    Minerva Med; 2004 Dec; 95(6):481-7. PubMed ID: 15785433
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Osteoporosis in patients with inflammatory bowel disease: risk factors, prevention, and treatment.
    Katz S
    Rev Gastroenterol Disord; 2006; 6(2):63-71. PubMed ID: 16699475
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Osteoporosis: prevention, diagnosis and therapy].
    Hennemann A
    Med Monatsschr Pharm; 2002 May; 25(5):164-7. PubMed ID: 12050922
    [No Abstract]   [Full Text] [Related]  

  • 57. [Clinical analysis of infectious complications following abdominal cluster transplantation].
    Chen HX; Yin L; Peng CH; Zhou GW; Shen BY; Chen GM; Chen CQ; Zhou HJ; Li HW
    Zhonghua Wai Ke Za Zhi; 2007 Mar; 45(5):319-22. PubMed ID: 17535710
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Caring for transplant recipients in a nontransplant setting.
    Hoffman FM; Nelson BJ; Drangstveit MB; Flynn BM; Watercott EA; Zirbes JM
    Crit Care Nurse; 2006 Apr; 26(2):53-66, 68-73; quiz 74. PubMed ID: 16565281
    [No Abstract]   [Full Text] [Related]  

  • 59. Cyclosporine-induced infantile nodulocystic acne.
    Strahan JE; Burch JM
    Arch Dermatol; 2009 Jul; 145(7):797-9. PubMed ID: 19620562
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Non-surgical periodontal therapy of cyclosporin A gingival overgrowth in organ transplant patients. Clinical results at 12 months.
    Aimetti M; Romano F; Priotto P; Debernardi C
    Minerva Stomatol; 2005 May; 54(5):311-9. PubMed ID: 15985985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.